img

Global Whole Genome Sequencing (WGS) Market Size By Product Type (Large Whole-Genome Sequencing (>5Mb), Small Genome Sequencing (<=5Mb)), By Application (Humanity, Plant), By Geographic Scope And Forecast


Published on: 2024-08-08 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Whole Genome Sequencing (WGS) Market Size By Product Type (Large Whole-Genome Sequencing (>5Mb), Small Genome Sequencing (<=5Mb)), By Application (Humanity, Plant), By Geographic Scope And Forecast

Whole Genome Sequencing (WGS) Market Size And Forecast

Whole Genome Sequencing (WGS) Market size was valued at USD 5.7 Billion in 2024 and is projected to reach USD 30.11 Billion by 2031, growing at a CAGR of 18.9% from 2024 to 2031.

The market’s growth has been influenced by the rapid advancement in technology for identifying genome sequencing. The rising number of cancer patients and genetic disorders are the primary growth drivers of the Global Whole Genome Sequencing (WGS) Market. The Global Whole Genome Sequencing (WGS) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Whole Genome Sequencing (WGS) Market Definition

Whole Genome Sequencing (WGS) seems to be the process of identifying the complete DNA sequence of an organism’s genome all at the same. This includes the sequencing of all organisms’ chromosomal DNA, mitochondrial DNA, and chloroplast DNA in plants. They are primarily used for research purposes. Genomic information is used to identify genetic disorders, track disease outbreaks, and characterize variations that contribute to cancer progression.

Though this method is typically associated with human genome sequencing, the next-generation sequencing technology can be used to identify the sequence of any species, including disease-related microbes, plants, and agriculturally prime livestock. Whole-genome sequencing can be used to identify newborn and pediatric diseases, rare tumor types, family disease pedigrees, and drug trials, among others.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Whole Genome Sequencing (WGS) Market Overview

The market overview section of this report mainly consists of the basic dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. The Global Whole Genome Sequencing (WGS) Market report provides an outlook on the development of the market in terms of revenue throughout the prognosis period. The global market is expected to experience remarkable growth in the upcoming years owing to the rapid advancement of technology for identifying genome sequencing, increasing number of cancer patients and genetic disorders are the primary growth drivers of the global market.

Whole Genome Sequencing is an excellent tool for understanding rare tumors. It allows the user to capture the entire range of variations, from single base changes to large chromosomal rearrangements, all at once. As the market is expanding, so has the demand for detecting cancer tumors. Furthermore, it aids in the survey of exotic regions, which are rarely captured and used to detect structural variants. The rapid turnaround time without the need for hybridization from single nucleotide variants to large deletions has created a huge demand in the newborn and pediatric sections.

This helps in the diagnosis and treatment of genetic disorders, thereby fueling the market growth. Moreover, increased research funding and investment programs in the genomics field have boosted demand for whole genome sequencing products, resulting in a larger market share. However, the high cost of sequencing procedures and the medical treatments associated with them, stringent regulatory standards, and high capital requirements are expected to hamper the growth of the Global Whole Genome Sequencing (WGS) Market over the forecast period.

Global Whole Genome Sequencing (WGS) Market Segmentation Analysis

The Global Whole Genome Sequencing (WGS) Market is segmented on the basis of Product Type, Application, And Geography.

Whole Genome Sequencing (WGS) Market, By Product Type

• Large Whole-Genome Sequencing (>5Mb)• Small Genome Sequencing (<=5Mb)

Based on Product Type, The market is segmented into Large Whole-Genome Sequencing (>5Mb) and Small Genome Sequencing (<=5Mb). The Large Whole-Genome Sequencing (>5Mb) segment accounts for the highest revenue share of the Global Whole Genome Sequencing (WGS) market in 2020 and is expected to dominate the market over the forecast period owing to increasing adoption due to its wide applications in research and population genetics. In addition, sequencing of large genomes which are more than 5Mb in sizes such as human, animal, or plant genomes, provides valuable disease insights which are driving the growth of this segment.

Whole Genome Sequencing (WGS) Market, By Application

• Humanity• Plant• Animal• Microorganism• Virus• Others

Based on Application, The market is segmented into Humanity, Plant, Animal, Microorganism, Virus, and Others. The Humanity segment is expected to hold the largest revenue share of the Global Whole Genome Sequencing (WGS) Market during the forecast period owing to an increased usage of human genome sequencing for early detection and diagnosis of various genetic disorders, newborn and pediatric diseases, rare tumor types and family disease pedigrees which will help to boost the growth of this segment.

Whole Genome Sequencing (WGS) Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global Whole Genome Sequencing (WGS) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Among the regional markets, North America accounts for the largest revenue share in the global Whole Genome Sequencing (WGS) Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of innovative and technologically advanced molecular diagnostic tests for the early diagnosis of various genetic disorders. Additionally, the rising prevalence of various genetic disorders and chronic diseases, growing consumer awareness about the early diagnosis, rising R&D sectors, well-established healthcare system, presence of skilled professionals, and wide availability of technologically advanced molecular diagnostic tests are the major driving factors that boost the market in the region.

Key Players

The “Global Whole Genome Sequencing (WGS) Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Illumina, Inc., Thermo Fisher Scientific, Inc., BGI, Nebula Genomics, Agilent Technologies, 10x Genomics, Qiagen N.V., GENEWIZ, Macrogen, Oxford Nanopore, Veritas Genetics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In 2021, with CDC support, Illumina partnered with Helix OpCo to improve the national surveillance infrastructure in the US in order to track the emergence and prevalence of novel strains of SARS-CoV-2. The integration of Illumina’s sequencing technology and expertise, along with Helix’s national COVID-19 testing footprint, will significantly expand the country’s existing surveillance efforts to detect and characterize emerging SARS-CoV-2 variants.

• In 2020, QIAGEN acquired NeuMoDx Molecular to strengthen its position as the market leader in automated molecular testing. QIAGEN’s portfolio will now include medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology.

• In 2020, Thermo Fisher Scientific introduced the Oncomine Myeloid Assay GX.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2021-2031

Base Year

2024

Forecast Period

2024-2031

Historical Period

2021-2023

Unit

Value (USD Billion)

Key Companies Profiled

Illumina, Inc., Thermo Fisher Scientific, Inc., BGI, Nebula Genomics, Agilent Technologies, 10x Genomics, Qiagen N.V.

Segments Covered
  •  By Product Type
  •  By Application
  •  By Geography
Customization Scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )